Rua Life Sciences Plc

Rua Life Sciences (RUA)

Company name:Rua Life Sciences Plc
EPIC:RUATrading Currency:GBX
Market Sector:AIMPISIN:GB0033360586
Market Segment:ASX1Share Type:DE
WWW Address: 5P
 Price Price Change [%] Bid Offer Open High Low Volume
 37.25 0.0 [0.00] 35.50 39.00 37.25 37.25 37.25 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 8.26 22.18 -0.05 -8.20 - - - 167.50 - 35.00

Rua Life Sciences Key Figures

(at previous day's close)
Market Cap.8.26m
Shares In Issue22.18m
Prev. Close37.25
PE Ratio- 
Dividend Yield-%
EPS - basic-8.20p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-6.37p
Return On Equity (ROE)-17.06%
Operating Margin-104.32%
PEG Factor- 
EPS Growth Rate-47.75%
Dividends PS Growth Rate-%
Net Debt-4.65m
Gross Gearing16.24%
Quick Assets7.33m
Net Working Capital6.23m
Intangibles / Fixed Assets30.95%
Turnover PS6.89p
Pre-Tax Profit PS-7.19p
Retained Profit PS-6.54p
Cash PS28.37p
Net Cash PS23.42p
Net Tangible Asset Value PS *34.40p
Net Asset Value PS38.34p
Spread3.50 (8.97%) 

Rua Life Sciences Balance Sheet


Share Price Performance

Sample Period HighLow
1 week37.2537.00
4 weeks43.5035.00
12 weeks49.5035.00
1 year167.5035.00

Share Price Chart (5 years)

Rua Life Sciences Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week37.25--37.000.0037.25
4 weeks43.50-6.25-14.3735.000.0237.62
12 weeks49.50-12.25-24.7535.000.0342.81
26 weeks72.00-34.75-48.2635.000.0451.08
1 year127.50-90.25-70.7835.000.0593.24
3 years55.50-18.25-32.8835.000.05104.81
5 years10.5026.75254.7610.500.0675.86

Rua Life Sciences Key Management Ratios

Rua Life Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.31 
Tobin's Q Ratio (excl. intangibles)1.43 
Dividend Yield-%
Market-to-Book Ratio0.97 
Price-to-Pre-Tax Profit PS-5.18 
Price-to-Retained Profit PS-5.70 
Price-to-Cash Flow PS-5.84 
Price-to-Sales PS5.41 
Price-to-Net Tangible Asset Value PS1.08 
Price-to-Cash PS1.31 
Net Working Capital PS28.08 
Price Pct to Working Capital PS1.33%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Rua Life Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio6.07%
Debt-to-Equity Ratio0.06 
Debt-to-Equity Ratio (excl. Intgbl)0.07 
Debt-to-Equity Market Value0.07 
Net Gearing-45.74%
Net Gearing (excl. Intangibles)-50.05%
Gross Gearing16.24%
Gross Gearing (excl. Intangibles)17.77%
Gearing Under 1 Year10.82%
Gearing Under 1 Year (excl. Intgbl)11.84%
(Liquidity Ratios)
Net Working Capital to Total Assets61.34%
Current Ratio6.67 
Quick Ratio (Acid Test)6.67 
Liquidity Ratio5.73 
Cash & Equiv/Current Assets85.89%
(Solvency Ratios)
Enterprise Value2.52m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.20 
Total Debt/Sales1.08 
Total Debt/Pre-Tax Profit-1.03 
Total Debt1.65m
Total Debt/Net Current Assets0.26%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs14 
Beta (60-Mnth)Beta (36-Mnth)

Rua Life Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-17.60%
Return On Assets (ROA)-22.94%
Net Profit Margin-94.96%
Assets Turnover0.24 
Return On Equity (ROE)-17.06%
Return On Investment (ROI)-25.61%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-94.96%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.28 
Fixed Assets Turnover0.99 
Current Assets Turnover0.32 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales4.14 
Debt Collection Period154.31Days

Rua Life Sciences Dividends

Sorry No Data Available

Rua Life Sciences Fundamentals

 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
pre tax profit-0.04--0.63--0.90--1.59-104.32%m
attributable profit-0.04--0.61--0.90--1.45-94.96%m
retained profit-0.04--0.61--0.90--1.45-94.96%m
eps - basic (p)-0.79 -4.72 -5.55 -8.20 
eps - diluted (p)-0.79 -4.72 -5.55 -8.20 
dividends per share- - - - 

Rua Life Sciences Balance Sheet

 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
fixed assets fixed assets--%0.000.03%0.010.20%1.9519.22%m
intangibles intangibles0.7448.61%0.4514.46%0.2610.22%0.888.62%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors0.1912.40%0.247.68%0.2610.34%1.0310.18%m
cash & securities cash & securities0.5938.98%2.4177.83%1.9879.23%6.2961.98%m
creditors - short creditors - short0.106.27%0.103.19%0.228.78%1.1010.82%m
creditors - long creditors - long--%--%--%0.555.42%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves1.4293.73%3.0096.81%2.2891.22%8.5183.76%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Rua Life Sciences Cash Flow Statement

31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
Operating CF0.50-0.42-0.44-1.41m
Pre-Financing CF0.48-0.56-0.44-2.37m
Retained CF0.481.99-0.444.32m

Rua Life Sciences Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Rua Life S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220706 09:38:10